Viz.ai
Focus: Viz.ai is a healthcare AI company specializing in medical image analysis for clinical decision support across neurology, cardiovascular, respiratory, and ophthalmology indications. The company operates as a software-based platform provider with $48.8M ARR and a $1.2B valuation as of 2022.
Profile data last refreshed 22h ago · AI intelligence enriched 3w ago
Open Jobs
0
About Viz.ai
AI assessmentNot HiringNo open roles listed right now. Follow Viz.ai to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Viz.ai's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
7 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Viz RECRUIT
Intracerebral HemorrhageViz ICH VOLUME
Intracerebral HemorrhageClinical Trials (1)
Help build intelligence for Viz.ai
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.